1007-3418
2013 Issue 6
Achieve a higher cure rate via standardized antiviral therapy for chronic hepatitis C
XIE Yao;LI Ming-hui
XIE Yao;LI Ming-hui
..............page:408-409
The difference of anti-virus effect between different modified antisense oligonucleotides in vitro
ZHU Xiao-ying;WANG Yan-fei
ZHU Xiao-ying;WANG Yan-fei
..............page:475-476
..............page:415-416
Relation of IL-17 polymorphisms and serum levels in patients with chronic HCV infection
nan yue min ; zhang yu guo ; kong ling bo ; zheng huan wei ; sun dian xing ; an chun mian ; li you sheng ; li cang you ; kong li
nan yue min ; zhang yu guo ; kong ling bo ; zheng huan wei ; sun dian xing ; an chun mian ; li you sheng ; li cang you ; kong li
..............page:425-428
Roles of full-length and truncated hepatitis B virus X protein and of interactions with the host-encoded damaged DNA binding protein 1 in HBV replication
YANG Xuan;HE Song;LUO Na;LUO Li;FAN Hao;GONG Qian
YANG Xuan;HE Song;LUO Na;LUO Li;FAN Hao;GONG Qian
..............page:446-451
..............page:401-402
Interleukin-32 expression is induced by hepatitis B virus
CAO Hong;PAN Xing-fei;ZHANG Ka;SHU Xin;LI Gang
CAO Hong;PAN Xing-fei;ZHANG Ka;SHU Xin;LI Gang
..............page:442-445
Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit α driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells
LI Dao-ming;LI Wei;TAO Min;CHEN Kai;GONG Fei-ran;XU Ze-kuan;CHEN Zheng
LI Dao-ming;LI Wei;TAO Min;CHEN Kai;GONG Fei-ran;XU Ze-kuan;CHEN Zheng
..............page:459-463
Distribution of HBV genotypes and clinical characteristics of HBV-related hepatocellular carcinoma patients in Deyang District,Sichuan Province
YANG Jia-hong;CHEN Gao;ZHANG Hao;CHEN Xue-bing;WANG Xiu;LUO Wan-rong
YANG Jia-hong;CHEN Gao;ZHANG Hao;CHEN Xue-bing;WANG Xiu;LUO Wan-rong
..............page:473-474
The relevant factors and strategies related efficacy with standard of care in chronic hepatitis C treatment naive patients
DOU Xiao-guang
DOU Xiao-guang
..............page:406-407
..............page:420-424
..............page:403-405
The difference of IL-28B polymorphisms between hepatitis C patients with and without cryoglobulinemia
fan xiao hong ; wu chi hong ; zheng ying ying ; wang li fen ; huo na ; shao cui ping ; lu hai ying ; xu xiao yuan ; wei lai
fan xiao hong ; wu chi hong ; zheng ying ying ; wang li fen ; huo na ; shao cui ping ; lu hai ying ; xu xiao yuan ; wei lai
..............page:429-433
Current perspectives on antiviral therapy in hepatitis C-infected patients with decompensated cirrhosis
ZHANG Hong-fei;ZHU Shi-shu
ZHANG Hong-fei;ZHU Shi-shu
..............page:413-414
Current advances in the understanding of HBeAg relation to immune tolerance
SONG Li;CHEN Tao;NING Qin
SONG Li;CHEN Tao;NING Qin
..............page:477-480
Orthogonal design based optimization of a mouse model of acute liver failure induced by D-galactosamine and lipopolysaccharide
yang zuo zhen ; chen zuo ; tong jing jing ; zhang hui ying ; zuo fei ; xu zhi heng ; xin shao jie ; hu zuo hua
yang zuo zhen ; chen zuo ; tong jing jing ; zhang hui ying ; zuo fei ; xu zhi heng ; xin shao jie ; hu zuo hua
..............page:464-466
Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis
wei dan dan ; yao min ; chen jie ; wang li ; yan mei juan ; gu xing ; qiu li wei ; dong zhi zhen ; yao deng fu
wei dan dan ; yao min ; chen jie ; wang li ; yan mei juan ; gu xing ; qiu li wei ; dong zhi zhen ; yao deng fu
..............page:452-458
Relation between serum levels of high mobility group box 1 and hepatitis B virus-related acute-on-chronic liver failure
DUAN Xue-zhang;HU Jin-hua;LI Chen;LIU Fang-fang;LIU Xiao-yan;TONG Jing-jing;XIN Shao-jie
DUAN Xue-zhang;HU Jin-hua;LI Chen;LIU Fang-fang;LIU Xiao-yan;TONG Jing-jing;XIN Shao-jie
..............page:434-437
Effect of antiviral therapy on the prognosis of patients with chronic hepatitis B-related cirrhosis
SONG Guang-jun;FENG Bo;RAO Hui-ying;WANG Jian;WEI Lai
SONG Guang-jun;FENG Bo;RAO Hui-ying;WANG Jian;WEI Lai
..............page:438-441
Hyperammonemia-induced hepatic injury in rats: Characterization of a new animal model
YU Zu-jiang;SUN Ran;LIU Xiao-rui;YAN Jing-ya;GAO Xiao-juan;JIA Bin;KAN Quan-cheng
YU Zu-jiang;SUN Ran;LIU Xiao-rui;YAN Jing-ya;GAO Xiao-juan;JIA Bin;KAN Quan-cheng
..............page:467-472
How to improve the efficacy of antiviral therapy on patients with hepatitis C related cirrhosis
FENG Bo;WEI Lai
FENG Bo;WEI Lai
..............page:410-412
Discussions on treatment failure causes and principles of chronic hepatitis C patients
XIE Qing;GUO Si-min
XIE Qing;GUO Si-min
..............page:417-419